NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.02
+0.41 (4.76%)
At close: Apr 28, 2026, 4:00 PM EDT
9.10
+0.08 (0.89%)
After-hours: Apr 28, 2026, 7:58 PM EDT
NeoGenomics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for NeoGenomics stock have an average target of 11.14, with a low estimate of 8.00 and a high estimate of 15. The average target predicts an increase of 23.50% from the current stock price of 9.02.
Analyst Consensus: Buy
* Price targets were last updated on Feb 24, 2026.
Analyst Ratings
The average analyst rating for NeoGenomics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +44.12% | Feb 24, 2026 |
| Needham | Needham | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +66.30% | Feb 17, 2026 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +55.21% | Jan 12, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +33.04% | Sep 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $6.5 → $11 | Buy | Maintains | $6.5 → $11 | +21.95% | Sep 2, 2025 |
Financial Forecast
Revenue This Year
804.64M
from 727.33M
Increased by 10.63%
Revenue Next Year
882.96M
from 804.64M
Increased by 9.73%
EPS This Year
0.16
from -0.84
EPS Next Year
0.32
from 0.16
Increased by 97.54%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 838.0M | 929.3M | |||
| Avg | 804.6M | 883.0M | |||
| Low | 778.2M | 843.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.2% | 15.5% | |||
| Avg | 10.6% | 9.7% | |||
| Low | 7.0% | 4.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.20 | 0.43 | |||
| Avg | 0.16 | 0.32 | |||
| Low | 0.09 | 0.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 169.1% | |||
| Avg | - | 97.5% | |||
| Low | - | 15.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.